Colonization with Staphylococcus Aureus and the Role of Colonization in Causing Infection

Staphylococci in Human Disease: Second Edition

Volumn , Issue , 2009, Pages 253-271

  Verbrugh, Henri A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Carriage of S. aureus by humans phenomenon associated with health and disease; Colonization with Staphylococcus aureus and colonization in infections; Diseases associated with increased carriage rates of S. aureus; Environmental determinants of carriage; Harmful carriage of S. aureus; Healthy carriage of S. aureus; Molecular and genetic determinants of S. aureus carriage; Staphylococcus aureus colonization occurring early in life

Indexed keywords

EID: 84876716222     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444308464.ch12     Document Type: Chapter

References (211)

1. Dolman CE. Clinical uses of Staphylococcus toxoid. Lancet 1935;i:306-13.
2. Williams REO. Healthy carriage of Staphylococcus: its prevalence and importance. Bacteriol Rev 1963;27:56-71.
3. Nilsson P, Ripa T. Staphylococcus aureus throat colonization is more frequent than colonization in the anterior nares. J Clin Microbiol 2006;44:3334-9.
4. Mertz D, Frei R, Jaussi B et al. Throat swabs are necessary to reliably detect carriers of Staphylococcus aureus. Clin Infect Dis 2007;45:475-7.
5. Solberg CO. Spread of Staphylococcus aureus in hospitals: causes and prevention. Scand J Infect Dis 2000;32:587-95.
6. Krstic RV. Human Microscopic Anatomy. An Atlas for Students of Medicine and Biology. Heidelberg: Springer Verlag, 1991.
7. Cole AM, Tahk S, Oren A et al. Determinants of Staphylococcus aureus nasal carriage. Clin Diagn Lab Immunol 2001;8:1064-9.
8. Clement S, Vaudaux P, Francois P et al. Evidence of an intracellular reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitis. J Infect Dis 2005;192:1023-8.
9. Leenders AC, Renders NR, Pelk M, Janssen M. Tonsilectomy for treatment of persistent methicillin-resistant Staphylococcus aureus throat carriage. J Hosp Infect 2005;59:266-7.
10. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997;10:505-20.
11. DeVriese LA. A simplified system for biotyping Staphylococcus aureus strains isolated from different animal species. J Appl Bacteriol 1984;56:215-30.
12. Van Leeuwen WB, Melles DC, Alaida A et al. Host- and tissuespecific pathogenic traits of Staphylococcus aureus. J Bacteriol 2005;187:4584-91.
13. Zadoks RN, van Leeuwen WB, Kreft D et al. Comparison of Staphylococcus aureus isolates from bovine and human skin,milking equipment, and bovine milk by phage typing, electrophoresis, and binary typing. J Clin Microbiol 2002;40:3894- 902.
14. Boost MV, O'Donoghue MM, James A. Prevalence of Staphylococcus aureus carriage among dogs and their owners. Epidemiol Infect 2008;136:953-64.
15. Dolman CE. The Staphylococcus: seven decades of research (1885-1955). Can J Med 1956;2:189-200.
16. Wertheim HFL, Melles DC, Vos MC, van Leeuwen W, Verbrugh HA, van Belkum A. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005;5:751-62.
17. Lestari ES, Severin JA, Filius PM et al. Antimicrobial resistance among commensal isolates of Escherichia coli and Staphylococcus aureus in the Indonesian population inside and outside hospitals. Eur J Clin Microbiol Infect Dis 2008;27:45-51.
18. Anwar MS, Jaffery G, Rehman Bhatti KU, Tayyib M, Bokhari SR. Staphylococcus aureus and MRSA nasal carriage in the general population. J Coll Physicians Surg Pak 2004;14:661-4.
19. Memish ZA, Balkhy H, Almuneef M, Al-Haj-Hussein B, Osaba A. Carriage of Staphylococcus aureus between Hajj pilgrims. Saudi Med J 2006;27:1367-72.
20. Choi CS, Yin CS, Bakar AA et al. Nasal carriage of Staphylococcus aureus among healthy adults. J Microbiol Immunol Infect 2006;39:458-64.
21. Lu PL, Chin LC, Peng CF et al. Risk factors and molecular analysis of community methicillin-resistant Staphylococcus aureus carriage. J Clin Microbiol 2005;43:132-9.
22. Saxena S, Singh K, Talwar V. Methicillin-resistant Staphylococcus aureus prevalence in the community in the East Delhi area. Jpn J Infect Dis 2003;56:54-6.
23. Block CS, Carmichael M. Community versus hospital Staphylococcus aureus. Antimicrobial susceptibilities and some features of nasal carriage and acquisition. S Afr Med J 1978;54:225-9.
24. Gorwitz RJ, Kruszon-Moran D, McAllister SK et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis 2008;197:1226-34.
25. Nulens E, Gould I, MacKenzie F et al. Staphylococcus aureus carriage among participants at the 13th European Congress of Clinical Microbiology and Infectious Diseases. Eur J Clin Microbiol Infect Dis 2005;24:145-8.
26. Wertheim HF, Vos MC, Ott A et al. Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients: a randomized study. Ann Intern Med 2004;140:419-25.
27. Bode LGM, Kluytmans JAJW, Wertheim HFL et al. A randomized trial of admission screening and decolonization of Staphylococcus aureus carriers to prevent nosocomial S. aureus infections. Abstract K-1711. Abstracts of the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 2008.
28. Shrestha NK, Banbury MK, Weber M et al. Safety of targeted perioperative mupirocin treatment for preventing infections after cardiac surgery. Ann Thorac Surg 2006;81:2183-8.
29. Perl TM, Cullen JJ, Wenzel RP et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 2002;346:1871-7.
30. Lucet JC, Grenet K, Armand-Lefevre L et al. High prevalence of carriage of methicillin-resistant Staphylococcus aureus at hospital admission in elderly patients: implications for infection control strategies. Infect Control Hosp Epidemiol 2005;26:121-6.
31. Hidron AI, Kourbatova EV, Halvosa JS et al. Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-acquired MRSA nasal carriage. Clin Infect Dis 2005;41:159-66.
32. Troillet N, Carmeli Y, Samore MH et al. Carriage of methicillinresistant Staphylococcus aureus at hospital admission. Infect Control Hosp Epidemiol 1998;19:181- 5.
33. Heininger U, Datta F, Gervaix A et al. Prevalence of nasal colonization with methicillin-resistant Staphylococcus aureus (MRSA) in children: a multicenter cross-sectional study. Pediatr Infect Dis J 2007;26:544-6.
34. Lamaro-Cardoso J, Castanheira M, de Oliveira RM et al. Carriage of methicillin-resistant Staphylococcus aureus in children in Brazil. Diagn Microbiol Infect Dis 2007;57:467-70.
35. Alfaro C, Masher-Denen M, Fergie J, Purcell K. Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in patients admitted to Driscoll Children's hospital. Pediatr Infect Dis J 2006;25:459-61.
36. Shopsin B, Mathema B, Martinez J et al. Prevalence of methicillinresistant and methicillin-susceptible Staphylococcus aureus in the community. J Infect Dis 2000;182:359-62.
37. Solberg CO. A study of carriers of Staphylococcus aureus with special regard to quantitative bacterial estimations. Acta Med Scand Suppl 1965;436:1-96.
38. Nouwen JL, Ott A, Kluytmans-VandenBergh MF et al. Predicting the Staphylococcus aureus nasal carrier state: derivation and validation of a "culture rule." Clin Infect Dis 2004;39:806- 11.
39. VandenBergh MFQ, Yzerman EPF, van Belkum A, Boelens HAM, Sijmons M, Verbrugh HA. Follow-up of Staphylococcus aureus nasal carriage after 8 years: redefining the persistent carrier state. J Clin Microbiol 1999;37:3133-40.
40. Nouwen J, Boelens H, van Belkum A, Verbrugh H. Human factor in Staphylococcus aureus nasal carriage. Infect Immun 2004;72:6685-8.
41. van Belkum A, Melles DC, Nouwen J et al. Co-evolutionary aspects of human colonisation and infection by Staphylococcus aureus. Infect Genet Evol 2009;9:32-47.
42. Hadley MDM. Nasal carriage of staphylococci in an Antarctic community. In: Macdonald M, Smith G, eds. The Staphylococci. Aberdeen: Aberdeen University Press, 1981:239-54.
43. Krikler SJ. Staphylococcus aureus in Antartica: carriage and attempted eradication. J Hyg 1986;97:427-44.
44. Eriksen NH, Espersen F, Rosdahl VT, Jensen K. Carriage of Staphylococcus aureus among 104 healthy persons during a 19-month period. Epidemiol Infect 1995;115:51-60.
45. Safdar N, Narans L, Gordon B, Maki DG. Comparison of culture screening methods for detection of nasal carriage of methicillin-resistant Staphylococcus aureus: a prospective study comparing 32 methods. J Clin Microbiol 2003;41:3163-6.
46. Crossley K, Solliday J. Comparison of rectal swabs and stool cultures for the detection of gastrointestinal carriage of Staphylococcus aureus. J Clin Microbiol 1980;11:433-4.
47. Compernolle V, Verschraegen G, Claeys G. Combined use of Pastorex Staph-Plus and either of two new chromogenic agars, MRSA ID and CHROMagar MRSA, for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2007;45:154-8.
48. Paule SM, Hacek DM, Kufner B et al. Performance of the BD GeneOhm methicillin-resistant Staphylococcus aureus test before and during high-volume clinical use. J Clin Microbiol 2007; 45:2993-8.
49. Lebon A, Labout JA, Verbrugh HA et al. Dynamics and determinants of Staphylococcus aureus carriage in infancy: the Generation R Study. J Clin Microbiol 2008;46:3517-21.
50. Harrison LM, Morris JA, Telford DR, Brown SM, Jones K. The nasopharyngeal bacterial flora in infancy: effects of age, gender, season, viral upper respiratory infection and sleeping position. FEMS Immunol Med Microbiol 1999;25:19-28.
51. Bogaert D, van Belkum A, Sluijter M et al. Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet 2004;363:1871-2.
52. Nouwen JL. Determinants, risks and dynamics of Staphylococcus aureus nasal carriage. Thesis, Erasmus University, Rotterdam, Netherlands, 2004.
53. Smith JA, O'Connor JJ. Nasal carriage of Staphylococcus aureus in diabetes mellitus. Lancet 1966;ii:776-7.
54. Tuazon CU, Perez A, Kishaba T, Sheagren JN. Staphylococcus aureus among insulin-injecting diabetic patients. An increased carrier rate. JAMA 1975;231:1272.
55. Chandler PT, Chandler SD. Pathogenic carrier rate in diabetes mellitus. Am J Med Sci 1977;273:259-65.
56. Lipsky BA, Pecoraro RE, Chen MS, Koepsell TD. Factors affecting staphylococcal colonization among NIDDM outpatients. Diabetes Care 1987;10:483-6.
57. Berman DS, Schaefler S, Simberkoff MS, Rahal JJ. Staphylococcus aureus colonization in intravenous drug abusers, dialysis patients, and diabetics. J Infect Dis 1987;155:829-31.
58. Boyko EJ, Lipsky BA, Sandoval R et al. NIDDM and prevalence of nasal Staphylococcus aureus colonization. San Luis Valley Diabetes Study. Diabetes Care 1989;12:189-92.
59. Mey A, Gille Y, Thivolet CH. Carriage of Staphylococcus aureus and local infections in diabetic outpatients treated with insulin pen. Diabetes Care 1990;13:451-2.
60. Tamer A, Karabay O, Ekerbicer H. Staphylococcus aureus nasal carriage and associated factors in type 2 diabetic patients. Jpn J Infect Dis 2006;59:10-14.
61. Philips BJ, Redman J, Brennan A et al. Glucose in bronchial aspirates increases the risk of respiratory MRSA in intubated patients. Thorax 2005;60:761-4.
62. Johnson LB, Jose J, Yousif F et al. Prevalence of colonization with community-associated methicillin-resistant Staphylococcus aureus among end-stage renal disease patients and healthcare workers. Infect Control Hosp Epidemiol 2009;30: 4-8.
63. Duran N, Ocak S, Eskiocak AF. Staphylococcus aureus nasal carriage among the diabetic and non-diabetic haemodialysis patients. Int J Clin Pract 2006;60:1204-9.
64. Chapoutot C, Pageaux GP, Perrigault PF et al. Staphylococcus aureus, nasal carriage in 104 cirrhotic and control patients: a prospective study. J Hepatol 1999;30:249-53.
65. Al-Rawahi GN, Schreader AG, Porter SD et al. Methicillinresistant Staphylococcus aureus nasal carriage among injection drug users: six years later. J Clin Microbiol 2008;46:477-9.
66. Karbay O, Tamer A, Sahin I, Celebi H. Does chronic hepatitis B increase Staphylococcus nasal carriage? Ethiop Med J 2006;44: 121-4.
67. Singh G, Rao DJ. Bacteriology of psoriatic plaques. Dermatologica 1978;157:21-7.
68. Gilani SJ, Gonzalez M, Hussain I, Finlay AY, Patel GK. Staphylococcus aureus re-colonization in atopic dermatitis: beyond the skin. Clin Exp Dermatol 2005;30:10-13.
69. Falanga V, Campbell DE, Leyden JJ, Douglas SD. Nasal carriage of Staphylococcus aureus and antistaphylococcal immunoglobulin E antibodies in atopic dermatitis. J Clin Microbiol 1985;22:452-4.
70. Goh CL, Wong JS, Giam YC. Skin colonization of Staphylococcus aureus in atopic dermatitis patients seen at the National Skin Centre, Singapore. Int J Dermatol 1997;36:653-7.
71. Kirmani N, Tuazon CU, Alling D. Carriage rate of Staphylococcus aureus among patients receiving allergy injections. Ann Allergy 1980;45:235-7.
72. Shiomori T, Yoshida S, Miyamoto H, Makishima K. Relationship of nasal carriage of Staphylococcus aureus to pathogenesis of perennial allergic rhinitis. J Allergy Clin Immunol 2000; 105:449-54.
73. Baysoy G, Arslan S, Karabay O, Uyan A. Nasal carriage of Staphylococcus aureus in children with allergic rhinitis and the effect of intranasal fluticasone propionate treatment on carriage status. Int J Pediatr Otorhinolaryngol 2007;71:205-9.
74. Riechelmann H, Essig A, Rau A, Rothermel B, Weschta M. Nasal carriage of Staphylococcus aureus in house dust mite allergic patients and healthy controls. Allergy 2005;60:1418-23.
75. Bassetti S, Dunagan DP, d'Agostino RB Jr, Sherertz RJ. Nasal carriage of Staphylococcus aureus among patients receiving allergeninjection immunotherapy: associated factors and quantitative nasal cultures. Infect Control Hosp Epidemiol 2001;22:741-5.
76. Damm M, Quante G, Jurk T, Sauer J. Nasal colonization with Staphylococcus aureus is not associated with the severity of symptoms or the extent of the disease in chronic rhinosinusitis. Otolaryngol Head Neck Surg 2004;131:200-6.
77. Clement S, Vaudaux P, Francois P et al. Evidence of an intracellular reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitis. J Infect Dis 2005;192:1023-8.
78. Jacobs SI, Williamson GM, Willis AT. Nasal abnormality and the carrier rate of Staphylococcus aureus. J Clin Pathol 1961;14:519-21.
79. Wertheim HF, van Kleef M, Vos MC, Ott A, Verbrugh HA, Fokkens W. Nose picking and nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol 2006;27:863-7.
80. Stegeman CA, Tervaert JWC, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CGM. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 1994;120:12-17.
81. Keser G, Erdogan M, Aydemir S et al. Nasal Staphylococcus aureus carriage is not increased in Behçet's disease. Rheumatol Int 2005;25:567-8.
82. Johnson RB, Muder RR, Kominos SD, Nasca TJ. Staphylococcal carriage and infection in myasthenia gravis patients receiving therapeutic apheresis. J Clin Apheresis 1988;4:155-7.
83. Bassetti S, Wasmer S, Hasler P et al. Staphylococcus aureus in patients with rheumatoid arthritis under conventional and anti-tumor necrosis factor-alpha treatment. J Rheumatol 2005; 32:2125-9.
84. Tabarya D, Hoffman WL. Staphylococcus aureus nasal carriage in rheumatoid arthritis: antibody response to toxic shock syndrome toxin-1. Ann Rheum Dis 1996;55:823-8.
85. Jackson MS, Bagg J, Gupta MN, Sturrock RD. Oral carriage of staphylococci in patients with rheumatoid arthritis. Rheumatology (Oxford) 1999;38:572-5.
86. Jobbins J, Bagg J, Parsons K, Finlay I, Addy M, Newcombe RG. Oral carriage of yeasts, coliforms and staphylococci in patients with advanced malignant disease. Oral Pathol Med 1992; 21:305-8.
87. Sweeney MP, Bag J, Baxter WP, Aitchison TC. Oral disease in terminally ill cancer patients with xerostomia. Oral Oncol 1998;34:123-6.
88. Herwaldt LA, Cullen JJ, French P et al. Preoperative risk factors for nasal carriage of Staphylococcus aureus. Infect Control Epidemiol 2004;25:481-4.
89. Amir LH, Garland SM, Lumley J. A case-control study of mastitis: nasal carriage of Staphylococcus aureus. BMC Fam Pract 2006;7:57.
90. Sheretz RJ. "Cloud" health-care workers. Emerg Infect Dis 2001;7:241-4.
91. Goslings WR, Buchli K. Nasal carrier rate of antibiotic-resistant staphylococci: influence of hospitalization on carrier rate in patients, and their household contacts. Arch Intern Med 1958;102:691-715.
92. Samad A, Banerjee D, Carnbarns N, Ghosh S. Prevalence of methicillin-resistant Staphylococcus aureus colonization in surgical patients, on admission to a Welsh hospital. J Hosp Infect 2002;51:43-6.
93. Lucet JC, Chevret S, Durand-Zaleski I, Chastang C, Regnier B. Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit: results of a multicenter study. Arch Intern Med 2003;163:181-8.
94. Fukuda M, Tanaka H, Kajiwara Y et al. High-risk populations for nasal carriage of methicillin-resistant Staphylococcus aureus. J Infect Chemother 2004;10:189-91.
95. Haley CC, Mittal D, Laviolette A, Jannapureddy S, Parvez N, Haley RW. Methicillin-resistant Staphylococcus aureus infection or colonization present at hospital admission: multivariable risk factor screening to increase efficiency of surveillance culturing. J Clin Microbiol 2007;45:3031-8.
96. Gopal Rao G, Michalczyk P, Nayeem N, Walker G, Wigmore L. Prevalence and risk factors for methicillin-resistant Staphylococcus aureus in adult emergency admissions: a case for screening all patients? J Hosp Infect 2007;66:15-21.
97. Berntsen CA, McDermott W. Increased transmissibility of staphylococci to patients receiving an antimicrobial drug. N Engl J Med 1960;262:637-42.
98. Barr B, Wilcox MH, Brady A, Parnell P, Darby B, Tompkins D. Prevalence of methicillin-resistant Staphylococcus aureus colonization among older residents of care homes in the United Kingdom. Infect Control Hosp Epidemiol 2007;28:853-9.
99. Kreman T, Hu J, Pottinger J, Herwaldt LA. Survey of longterm-care facilities in Iowa for policies and practices regarding residents with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci. Infect Control Hosp Epidemiol. 2005;26:811-15.
100. Eveillard M, Martin Y, Hidri N, Boussougant Y, Joly-Guillou ML. Carriage of methicillin-resistant Staphylococcus aureus among hospital employees: prevalence, duration, and transmission to households. Infect Control Hosp Epidemiol 2004;25:114-20.
101. Reboli AC, John IF Jr, Platt CG, Cantey JR. Methicillin-resistant Staphylococcus aureus outbreak at a Veterans Affairs Medical Center: importance of carriage of the organism by hospital personnel. Infect Control Hosp Epidemiol 1990;11:291-6.
102. Simoons-Smit AM, Savelkoul PH, Stoof J, Starink TM, Vandenbroucke-Grauls CM. Transmission of Staphylococcus aureus between humans and domestic animals in a household. Eur J Clin Microbiol Infect Dis 2000;19:150-2.
103. Weese JS, Dick H, Willey BM et al. Suspected transmission of methicillin-resistant Staphylococcus aureus between domestic pets and humans in veterinary clinics and in the household. Vet Microbiol 2006;115:148-55.
104. Hota B, Ellenbogen C, Hayden MK, Aroutcheva A, Rice TW, Weinstein RA. Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections at a public hospital: do public housing and incarceration amplify transmission? Arch Intern Med 2007;167:1026-33.
105. Aiello AE, Lowy FD, Wright LN, Larson EL. Methicillinresistant Staphylococcus aureus among US prisoners and military personnel: review and recommendations for future studies. Lancet Infect Dis 2006;6:335-41.
106. Adcock PM, Pastor P, Medley F, Patterson JE, Murphy TV. Methicillin-resistant Staphylococcus aureus in two child care centers. J Infect Dis 1998;178:577-80.
107. Jensen JU, Jensen ET, Larsen AR et al. Control of a methicillinresistant Staphylococcus aureus (MRSA) outbreak in a day-care institution. J Hosp Infect 2006;63:84-92.
108. Pagac BB, Reiland RW, Bolesh DT, Swanson DL. Skin lesions in barracks: consider community-acquired methicillin-resistant Staphylococcus aureus infection instead of spider bites. Milit Med 2006;171:830-2.
109. Reinberg J, Ailor SK, Dyer JA. Common sports-related dermatologic infections. Mod Med 2007;104:119-23.
110. Kazakova SV, Hageman JC, Matava M et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 2005;352:468-75.
111. Barnham M, Kerby J. A profile of skin sepsis in meat handlers. J Infect 1984;9:43-50.
112. Decker MD, Lybarger JA, Vaughn WK, Hutcheson RH Jr, Schaffner W. An outbreak of staphylococcal skin infections among river rafting guides. Am J Epidemiol 1986;124:969- 76.
113. Armand-Lefevre L, Ruimy R, Andremont A. Clonal comparison of of Staphylococcus aureus isolates from healthy pig farmers, human controls, and pigs. Emerg Infect Dis 2005;11:711-14.
114. Mahdi SE, Ahmed AO, Boelens H et al. An epidemiological study on the occurrence of Staphylococcus aureus in superficial abscesses of patients presenting for surgery in a teaching hospital in Khartoum, Sudan. FEMS Immunol Med Microbiol 2000;29:155-62.
115. Agarwal AK, Sethi A, Sethi D, Mrig S, Chopra S. Role of socioeconomic factors in deep neck abscess: a prospective study of patients. Br J Oral Maxillofac Surg 2007;45:553-5.
116. Nickerson EK, Wuthiekanun V, Day NP, Chaowagul W, Peacock SJ. Methicillin-resistant Staphylococcus aureus in rural Asia. Lancet Infect Dis 2006;6:70-1.
117. Bagger JP, Zindrou D, Taylor KM. Postoperative infection with methicillin-resistant Staphylococcus aureus and socioeconomic background. Lancet 2004;363:706-8.
118. Noble WC, Williams RE, Jevons MP, Shooter RA. Some aspects of nasal carriage of staphylococci. J Clin Pathol 1964;17:79-83.
119. Miles AA, Williams REO, Clayton-Cooper B. The carriage of Staphylococcus (pyogenes) aureus in man and its relation to wound infection. J Pathol Bacteriol 1944;56:513-56.
120. Heczko PB, Hoffler U, Kasprowicz A, Pulverer G. Quantitative studies of the flora of the nasal vestibule in relation to nasal carriage of Staphylococcus aureus. J Med Microbiol 1981;14:233-41.
121. Rountree PM, Barbour RG. Nasal carrier rates of Staphylococcus pyogenes in hospital nurses. J Pathol Bacteriol 1951;63:313-24.
122. Dall'Antonia M, Coen PG, Wilks M, Whiley A, Millar M. Competition between methicillin-sensitive and -resistant Staphylococcus aureus in the anterior nares. J Hosp Infect 2005;61:62 -7.
123. Shinefield HR, Wilsey JD, Ribble JC, Boris M, Eichenwald HF, Dittmar CI. Interactions of staphylococcal colonization. Influence of normal nasal flora and antimicrobials on inoculated Staphylococcus aureus strain 502A. Am J Dis Child 1966;111: 11-21.
124. Aly R, Maibach HI, Shinefield HR, Mandel A, Strauss WG. Bacterial interference among strains of Staphylococcus aureus in man. J Infect Dis 1974;129:720-4.
125. Regev-Yochay G, Trzcinski K, Thompson CM, Malley R, Lipsitch M. Interference between Streptococcus pneumoniae and Staphylococcus aureus: in vitro hydrogen peroxide-mediated killing by Streptococcus pneumoniae. J Bacteriol 2006;188:4996- 5001.
126. Watson K, Carville K, Bowman J et al. Upper respiratory tract bacterial carriage in Aboriginal and non-Aboriginal children in a semi-arid area of Western Australia. Pediatr Infect Dis J 2006;25:782-90.
127. Melles DC, Bogaert D, Gorkink RF et al. Nasopharyngeal cocolonization with Staphylococcus aureus and Streptococcus pneumoniae in children is bacterial genotype independent. Microbiology 2007;153:386-92.
128. Uehara Y, Nakama H, Agematsu K et al. Bacterial interference among nasal inhabitants: eradication of Staphylococcus aureus from nasal cavities by artificial implantation of Corynebacterium sp. J Hosp Infect 2000;44:127-33.
129. Ji G, Beavis R, Novick RP. Bacterial interference caused by autoinducing peptide variants. Science 1997;276:2027-30.
130. Lina G, Boutite F, Tristan A, Bes M, Etienne J, Vandenesch F. Bacterial competition for human nasal cavity colonization: role of staphylococcal agr alleles. Appl Environ Microbiol 2003;69:18-23.
131. van Leeuwen W, van Nieuwenhuizen W, Gijzen C, Verbrugh H, van Belkum A. Population studies of methicillin-resistant and -sensitive Staphylococcus aureus strains reveal a lack of variability in the agrD gene, encoding a staphylococcal autoinducer peptide. J Bacteriol 2000;182:5721-9.
132. Kaliner MA. Human nasal respiratory secretions and host defense. Am Rev Respir Dis 1991;144:S52-S56.
133. Cole AM, Dewan P, Ganz T. Innate antimicrobial activity of nasal secretions. Infect Immun 1999;67:326-75.
134. Bera A, Herbert S, Jakob A, Vollmer W, Gotz F. Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus. Mol Microbiol 2005;55:778-87.
135. Nagaoka I, Hirota S, Yomogida S, Ohwada A, Hirata M. Synergistic actions of antibacterial neutrophil defensins and cathelicidins. Inflamm Res 2000;49:73-9.
136. Ong PY, Ohtake T, Brandt C et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002;347:1151-60.
137. Peschel A, Jack RW, Otto M et al. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med 2001;193:1067-76.
138. Verbrugh HA, Peters R, Goessens WH, Michel MF. Distinguishing complicated from uncomplicated bacteremia caused by Staphylococcus aureus: the value of "new" and "old" serological tests. J Immunol 1986;153:109-15.
139. Verbrugh HA, Peterson PK, Nguyen BY, Sisson SP, Kim Y. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement. J Immunol 1982;129:1681-7.
140. Lee JC. The prospects for developing a vaccine against Staphylococcus aureus. Trends Microbiol 1996;4:162-6.
141. Sanford BA, Thomas VL, Ramsay MA. Binding of staphylococci to mucus in vivo and in vitro. Infect Immun 1989;57:3735- 42.
142. Shuter J, Hatcher VB, Lowy FD. Staphylococcus aureus binding to human nasal mucin. Infect Immun 1996;64:310-18.
143. Carruthers MM, Kabat WJ. Mediation of staphylococcal adherence to mucosal cells by lipoteichoic acid. Infect Immun 1983;40:444-6.
144. Schwab UE, Wold AE, Carson JL et al. Increased adherence of Staphylococcus aureus from cystic fibrosis lungs to airway epithelial cells. Am Rev Respir Dis 1993;148:365-9.
145. Bibel DJ, Aly R, Shinefield HR, Maibach HI, Strauss WG. Importance of the keratinized epithelial cell in bacterial adherence. J Invest Dermatol 1982;79:250-3.
146. Aly R, Shinefield HI, Strauss WG, Maibach HI. Bacterial adherence to nasal mucosal cells. Infect Immun 1977;17:546- 9.
147. Corrigan RM, Rigby D, Handley P, Foster TJ. The role of Staphylococcus aureus surface protein SasG in adherence and biofilm formation. Microbiology 2007;153:2435-46.
148. Walsh EJ, O'Brien LM, Liang X, Hook M, Foster TJ. Clumping factor B, a fibrinogen-binding MSCRAMM (microbial surface components recognizing adhesive matrix molecules) adhesin of Staphylococcus aureus, also binds to the tail region of type I cytokeratin 10. J Biol Chem 2004;279:50691-9.
149. O'Brien LM, Walsh EJ, Massey RC, Peacock SJ, Foster TJ. Staphylococcus aureus clumping factor B (ClfB) promotes adherence to human type I cytokeratin 10: implications for nasal colonization. Cell Microbiol 2002;4:759-70.
150. Schaffer AC, Solinga RM, Cocchiaro J et al. Immunization with Staphylococcus aureus clumping factor B, a major determinant in nasal carriage, reduces nasal colonization in a murine model. Infect Immun 2006;74:2145-53.
151. Clarke SR, Brummell KJ, Horsburgh MJ et al. Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage. J Infect Dis 2006;193:1098-108.
152. Aly R, Levit S. Adherence of Staphylococcus aureus to squamous epithelium: role of fibronectin and teichoic acid. Rev Infect Dis 1987;9(suppl 4):S341-S350.
153. Weidemaier C, Kokai-Fun JF, Kristian SA et al. Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat Med 2004;10:243-5.
154. Foster TJ. Nasal colonization by Staphylococcus aureus. Nat Med 2004;10:447.
155. Wertheim HFL, Walsh E, Choudhurry R et al. Key role for clumping factor B in Staphylococcus aureus nasal colonization of humans. PLoS Med 2008;5:e17.
156. Hoeksma A, Winkler KC. The normal flora of the nose in twins. Acta Leidensia 1963;32:123-33.
157. Aly R, Maibach HI, Shinefield HR, Mandel AD. Staphylococcus aureus carriage in twins. Am J Dis Child 1974;127:486-8.
158. Kinsman OS, McKenna R, Noble WC. Association between histocompatability antigens (HLA) and nasal carriage of Staphylococcus aureus. J Med Microbiol 1983;16:215-20.
159. van den Akker EL, Nouwen JL, Melles DC et al. Staphylococcus aureus nasal carriage is associated with glucocorticoid receptor gene polymorphisms. J Infect Dis 2006;194:814-18.
160. Emonts M, de Jongh CE, Houwing-Duistermaat JJ et al. Association between nasal carriage of Staphylococcus aureus and the human complement cascade activator serine protease C1 inhibitor (C1INH) valine vs. methionine polymorphism at amino acid position 480. FEMS Immunol Med Microbiol 2007;50:330-2.
161. Emonts M, Uitterlinden AG, Nouwen JL et al. Host polymorphisms in interleukin 4, complement factor H and C-reactive protein associated with nasal carriage of Staphylococcus aureus and occurrence of boils. J Infect Dis 2008;197:1244 -53.
162. van Belkum A, Emonts M, Wertheim H et al. The role of human innate immune factors in nasal colonization by Staphylococcus aureus. Microbes Infect 2007;9:1471-7.
163. Claassen M, Nouwen J, Fang Y et al. Staphylococcus aureus nasal carriage is not associated with known polymorphism in the vitamin D receptor gene. FEMS Immunol Med Microbiol 2005;43:173-6.
164. Miller DL, McDonald JC, Jevons MP, Williams REO. Staphylococcal disease and nasal carriage in the Royal Air Force. J Hyg 1962;60:451-65.
165. Atkins JB, Marks J. The role of staphylococcal infection in beat disorders of miners. Br J Ind Med 1952;9:296-302.
166. Chow AW, Bartlett KH, Percival-Smith R, Morrison BJ. Vaginal colonization with Staphylococcus aureus, positive for toxic-shock marker protein, and Escherichia coli in healthy women. J Infect Dis 1984;150:80-4.
167. Tuazon CU, Sheagren JN. Staphylococcal endocarditis in parenteral drug abusers: source of the organism. Ann Intern Med 1975;82:788-90.
168. Gillespie WJ, Haywood-Farmer M, Fong R, Harding SM. Aspects of the microbe-host relationship in staphylococcal hematogenous osteomyelitis. Orthopedics 1987;10:475-80.
169. Niclaes L, Buntinx F, Banuro F, Lesaffre E, Heyrman J. Consequences of MRSA carriage in nursing home residents. Epidemiol Infect 1999;122:235-9.
170. Jensen AG, Wachmann CH, Poulsen KB et al. Risk factors for hospital-acquired Staphylococcus aureus bacteremia. Arch Intern Med 1999;159:1437-44.
171. Muder RR, Brennen C, Wagener MM et al. Methicillin-resistant staphylococcal colonization and infection in a long-term care facility. Ann Intern Med 1991;114:107-12.
172. Chang FY, Singh N, Gayowski T, Drenning SD, Wagener MM, Marino IR. Staphylococcus aureus nasal colonization and association with infection in liver transplantation recipients. Transplantation 1998;65:1169-72.
173. Chang FY, Singh N, Gayowski T, Wagener MM, Marino IR. Staphylococcus aureus nasal colonization in patients with cirrhosis: prospective assessment of association with infection. Infect Control Hosp Epidemiol 1998;19:328-32.
174. Mest DR, Wong DH, Shimoda KJ, Mulligan ME, Wilson SE. Nasal colonization with methicillin-resistant Staphylococcus aureus on admission to the surgical intensive care unit increases the risk of infection. Anesth Analg 1994;78:644-50.
175. Corbella X, Dominguez MA, Pujol M et al. Staphylococcus aureus nasal carriage as a marker for subsequent staphylococcal infections in intensive care unit patients. Eur J Clin Microbiol Infect Dis 1997;16:351-7.
176. Zimakoff J, Pedersen FB, Bergen L et al. Staphylococcus aureus carriage and infections among patients in four haemo- and peritoneal dialysis centres in Denmark. J Hosp Infect 1996; 33:289-300.
177. Lye WC, Leong SO, van der Straaten J, Lee EJC. Staphylococcus aureus CAPD related infections are associated with nasal carriage. Adv Perit Dial 1994;10:163-5.
178. Weinke T, Schiller R, Fehrenbach FJ, Pohle HD. Association between Staphylococcus aureus nasopharyngeal colonization and septicemia in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis 1992;11:985-9.
179. Bert F, Galdbart J-O, Zarrouk V et al. Association between nasal carriage of Staphylococcus aureus and infection in liver transplant recipients. Clin Infect Dis 2000;31:1295-9.
180. Jakob HG, Borneff-Lipp M, Bach A et al. The endogenous pathway is a major route for deep sternal wound infection. Eur J Cardiothorac Surg 2000;17:154-60.
181. Kalmeijer MD, van Nieuwland-Bollen E, Bogaers-Hofman D, de Baere GA. Nasal carriage of Staphylococcus aureus is a major risk factor for surgical-site infections in orthopedic surgery. Infect Control Hosp Epidemiol 2000;21:319-23.
182. Fierobe L, Decré D, Mùller C et al. Methicillin-resistant Staphylococcus aureus as a causative agent of postoperative intra-abdominal infection: relation to nasal colonization. Clin Infect Dis 1999;29:1231-8.
183. Desai D, Desai N, Nightingale P, Elliott T, Neuberger J. Carriage of MRSA is associated with an increased risk of infection after liver transplantation. Liver Transpl 2003;9:754- 9.
184. Squier C, Rihs JD, Risa KJ et al. Staphylococcus aureus rectal carriage and its association with infections in patients in a surgical intensive care unit and a liver transplant unit. Infect Control Hosp Epidemiol 2002;23:495-501.
185. Saxena AK, Panhotra BR, Venkateshappa CK, Sundaram DS, Uzzaman NM, Al Mulhim K. The impact of nasal carriage of methicillin-resistant and methicillin-susceptible Staphylococcus aureus (MRSA and MSSA) on vascular access-related septicemia among patients with type-II diabetes on dialysis. Ren Fail 2002;24:763-77.
186. Dupeyron C, Campillo SB, Mangeney N, Richardet JP, Leluan G. Carriage of Staphylococcus aureus and of gram-negative bacilli resistant to third-generation cephalosporins in cirrhotic patients: a prospective assessment of hospital-acquired infections. Infect Control Hosp Epidemiol 2001;22:427-33.
187. Tulloch LG, Alder VG, Gillespie WA. Treatment of chronic furunculosis. BMJ 1960;2:354-6.
188. Nouwen JL, Fieren MW, Snijders S, Verbrugh HA, van Belkum A. Persistent (not intermittent) nasal carriage of Staphylococcus aureus is the determinant of CPD-related infections. Kidney Int 2005;67:1084-93.
189. Talon D, Rouget C, Cailleaux V et al. Nasal carriage of Staphylococcus aureus and cross-contamination in a surgical intensive care unit: efficacy of mupirocin ointment. J Hosp Infect 1995;30:39-49.
190. Gawler DM, Royle JP, Tosolini FA. Intractable nasal carriage of methicillin-resistant Staphylococcus aureus. Med J Aust 1980; 11:607-8.
191. Mitsuda T, Arai K, Ibe M, Imagawa T, Tomono N, Yokota S. The influence of methicillin-resistant Staphylococcus aureus (MRSA) carriers in a nursery and transmission of MRSA to their households. J Hosp Infect 1999;42:45-51.
192. Cetinkaya Y, Kocagoz S, Hayran M et al. Analysis of a mini-outbreak of methicillin-resistant Staphylococcus aureus in a surgical ward by using arbitrarily primed-polymerase chain reaction. J Chemother 2000;12:138-44.
193. Fascia P, Martin I, Mallaval FO et al. Possible implication of student nurses in the transmission of methicillin-resistant Staphylococcus aureus during a nosocomial outbreak. Pathol Biol 2003;51:479-82.
194. Cookson B, Peters B, Webster M, Phillips I, Rahman M, Noble W. Staff carriage of epidemic methicillin-resistant Staphylococcus aureus. J Clin Microbiol 1989;27:1471-6.
195. Ben-David D, Mermel LA, Parenteau S. Methicillin-resistant Staphylococcus aureus transmission: the possible importance of unrecognized health care worker carriage. Am J Infect Control 2008;36:93-7.
196. Cespedes C, Miller M, Quagliarello B, Vavagiakis P, Klein RS, Lowy FD. Differences between Staphylococcus aureus isolates from medical and nonmedical hospital personnel. J Clin Microbiol 2002;40:2594-7.
197. Tammelin A, Klotz F, Hambraeus A, Stahle E, Ransjo U. Nasal and hand carriage of Staphylococcus aureus in staff at a department for thoracic and cardiovascular surgery: endogenous or exogenous source? Infect Control Hosp Epidemiol 2003;24:686-9.
198. Sowirka O, Carron A, Perri M, Zervos M, Hyde K, Maddens M. Prevalence of Staphylococcus aureus carriage among asymptomatic nursing home personnel: a pilot study. J Am Med Dir Assoc 2000;1:159-63.
199. Kluytmans JA, Wertheim HF. Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections. Infection 2005;33:3-8.
200. Doebbeling BN. Nasal and hand carriage of Staphylococcus aureus in healthcare workers. J Chemother 1994;6(suppl 2):11-17.
201. Watanakunakorn C, Axelson C, Bota B, Stahl C. Mupirocin ointment with and without chlorhexidine baths in the eradication of Staphylococcus aureus nasal carriage in nursing home residents. Am J Infect Control 1995;23:306-9.
202. Mupirocin Study Group. Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. J Am Soc Nephrol 1996;7:2403-8.
203. Segers P, Speekenbrink RG, Ubbink DT, van Ogtrop ML, de Mol BA. Prevention of nosocomial infection in cardiac surgery by decontamination of the nasopharynx and oropharynx with chlorhexidine gluconate: a randomized controlled trial. JAMA 2006;297:1059-60.
204. McAnally TP, Lewis MR, Brown DR. Effect of rifampin and bacitracin on nasal carriers of Staphylococcus aureus. Antimicrob Agents Chemother 1984;25:422-6.
205. Yu VL, Goetz A, Wagener M et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. N Engl J Med 1986;315:91-6.
206. Mody L, Kauffman CA, McNeil SA, Galecki AT, Bradley SF. Mupirocin-based decolonization of Staphylococcus aureus carriers in residents of two long-term care facilities: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2003;37: 1467-74.
207. van Rijen M, Bonten M, Wenzel R, Kluytmans J. Intranasal mupirocin for reduction of S. aureus infections in surgical patients with nasal carriage. J Antimicrob Chemother 2008;61:254-61.
208. Boelaert JR, Van Landuyt HW, Godard CA et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. Nephrol Dial Transplant 1993;8:235-9.
209. Boelaert JR, Van Landuyt HW, Gordts BZ, De Baere YA, Messer SA, Herwaldt LA. Nasal and cutaneous carriage of Staphylococcus aureus in hemodialysis patients: the effect of nasal mupirocin. Infect Control Hosp Epidemiol 1996;17:809-11.
210. Shinefield HR, Ribble JC, Boris M, Eichenwald H, Aly R, Maibach H. Bacterial interference between strains of S. aureus. Ann NY Acad Sci 1974;236:444-55.
211. Wertheim HF, Vos MC, Ott A et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 2004;364:703-5.